EliLouisDiamondMD

Neurooncology

Instructor, Neurology, Weill Cornell Med College

Overview of Dr. Diamond

Dr. Eli Diamond is a neurologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center and Memorial Hospital for Cancer and allied Diseases. He received his medical degree from Albert Einstein College of Medicine of Yeshiva University and has been in practice 10 years. He is one of 57 doctors at Memorial Sloan Kettering Cancer Center and one of 6 doctors at Memorial Hospital for Cancer and allied Diseases who specialize in Neurology. He has more than 100 publications and over 500 citings.

Office
1275 York Ave
Department of Neurology Box 52
New York, NY 10065
Book by Phone+1(917) 993-9628
Is this information wrong?

Education & Training

Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Neurology, 2008 - 2011
Icahn School of Medicine at Mount Sinai (Beth Israel)Residency, Internal Medicine, 2007 - 2008
Albert Einstein College of MedicineClass of 2007

Certifications & Licensure

FL State Medical License 2022 - Present
NJ State Medical License 2022 - 2025
NY State Medical License 2011 - 2024
NC State Medical License 2020 - 2022
MA State Medical License 2009 - 2012
American Board of Psychiatry and Neurology Neurology

Clinical Trials

Prognostic Awareness and Patient-Physician Communication in Malignant Glioma Start of enrollment: 2013 Dec 01
Completed
Long-term Outcome After Vemurafenib / BRAF Inhibitors Interruption in Erdheim-chester Disease Start of enrollment: 2014 Mar 01
Unknown status
Single-agent Cobimetinib for Adults With Histiocytic Disorders Start of enrollment: 2016 Jan 01
Completed
Phase 2
A Study of Memory, Thinking, and Brain Imaging in Adults With Histiocytosis Start of enrollment: 2017 Apr 07
Active, not recruiting
Registry for Patients With Erdheim-Chester Disease and Other Histiocytoses Start of enrollment: 2017 Oct 26
Recruiting
Supportive Care Needs of Caregivers of People With Erdheim-Chester Disease and Other Histiocytic Diseases Start of enrollment: 2019 Jun 14
Recruiting
Join now to see all

Publications & Presentations

PubMed

Mutant PIK3CA is a targetable driver alteration in histiocytic neoplasms.
Benjamin H Durham, Oshrat Hershkovitz-Rokah, Omar Abdel-Wahab, Mariko Yabe, Young Rock Chung, Gilad Itchaki, Maayan Ben-Sasson, Vered A Asher-Guz, David Groshar, Seyra...> ;Blood Advances. 2023 Dec 12
Histiocytic neoplasm subtypes differ in their MAP2K1 mutational type.
Jean-François Emile, Zofia Hélias-Rodzewicz, Benjamin H Durham, Sébastien Héritier, Malik da Silva, Komel Younas, Fleur Cohen-Aubart, Omar Abdel-Wahab, Eli L Diamond, ...> ;Blood Advances. 2023 Dec 12
Erdheim-Chester Disease Due to a Novel Internal Duplication of NRAS: Response to Targeted Therapy with Cobimetinib.
José A Riancho, José L Hernández, Carmen González-Vela, Ana E López-Sundh, Marcos A González-Lopez, Francisco Gomez de la Fuente, Remedios Quirce, Eli L Diamond> ;International Journal of Molecular Sciences. 2023 Oct 23
Dyadic communication in rare cancer: a registry-based study of patients with Erdheim-Chester disease and their caregivers.
Anne S Reiner, Allison J Applebaum, Dana Bossert, Justin J Buthorn, Allison M Sigler, Deanna Fournier, Kathleen Brewer, Thomas M Atkinson, Kathleen A Lynch, Jaime Gill...> ;Blood Advances. 2023 Oct 10
Childhood-onset Erdheim-Chester disease in the molecular era: clinical phenotypes and long-term outcomes of 21 patients.
Francesco Pegoraro, Martina Mazzariol, Irene Trambusti, Sameer Bakhshi, Saumyaranjan Mallick, Ira J Dunkel, Cor van den Bos, Özlem Tezol, Shijun Shan, Suheyla Ocak, Fl...> ;Blood. 2023 Sep 28
Genome-Wide Association Study Identifies the First Germline Genetic Variant Associated With Erdheim-Chester Disease.
Javier Martínez-López, Ana Márquez, Francesco Pegoraro, Lourdes Ortiz-Fernández, Marialbert Acosta-Herrera, Martin Kerick, Elena Gelain, Eli L Diamond, Benjamin H Durh...> ;Arthritis & Rheumatology. 2024 Jan 1
5 citations
Successful treatment of non-Langerhans cell histiocytosis with the MEK inhibitor trametinib: a multicenter analysis.
Ashley Aaroe, Razelle Kurzrock, Gaurav Goyal, Aaron M Goodman, Harsh Patel, Gordon Ruan, Gary Ulaner, Jason Young, Ziyi Li, Derek Dustin, Ronald S Go, Eli L Diamond, F...> ;Blood Advances. 2023 Aug 8
5 citations
Outcomes after interruption of targeted therapy in patients with histiocytic neoplasms.
Anne S Reiner, Benjamin H Durham, Mariko Yabe, Kseniya Petrova-Drus, Jasmine H Francis, Raajit K Rampal, Mario E Lacouture, Veronica Rotemberg, Omar Abdel-Wahab, Kathe...> ;British Journal of Haematology. 2023 Nov 1
1 citations
CSF1R inhibition for histiocytic neoplasm with CBL mutations refractory to MEK1/2 inhibition.
Eli L Diamond, Jasmine H Francis, Mario E Lacouture, Veronica Rotemberg, Mariko Yabe, Kseniya Petrova-Drus, Gary A Ulaner, Ryan Reddy, Omar Abdel-Wahab, Benjamin H Durham> ;Leukemia. 2023 Aug 1
Advances in palliative care in neuro-oncology come in many forms.
Eli L Diamond> ;Neuro-Oncology. 2023 Mar 14
2 citations
Challenges and positive impact of rare cancer caregiving: A mixed-methods study of caregivers of patients with Erdheim-Chester disease and other histiocytic neoplasms.
Hannah-Rose Mitchell, Allison J Applebaum, Kathleen A Lynch, Anne S Reiner, Thomas M Atkinson, Justin J Buthorn, Allison S Sigler, Dana Bossert, Kathleen Brewer, Jessi...> ;Eclinicalmedicine. 2022 Dec 1
Treatment-Refractory Nodular Scleritis.
Jasmine H Francis, Y Pierre Gobin, Eli L Diamond> ;JAMA Ophthalmology. 2022 Sep 15
Development and feasibility of a communication training to assist caregivers with advanced care planning.
Allison J Applebaum, Rebecca Gebert, Mia Behrens, Morgan Loschiavo, Patricia A Parker, Kelly M Shaffer, Alan Carver, Eli L Diamond> ;Palliative & Supportive Care. 2022 Sep 14
10 citations
Meaning-Centered Psychotherapy for Cancer Caregivers: A pilot trial among caregivers of patients with glioblastoma multiforme.
Allison J Applebaum, Raymond E Baser, Kailey E Roberts, Kathleen Lynch, Rebecca Gebert, William S Breitbart, Eli L Diamond> ;Translational Behavioral Medicine. 2022 Aug 17
5 citations
Multi-institutional study of the frequency, genomic landscape, and outcome of IDH-mutant glioma in pediatrics.
Kee Kiat Yeo, Sanda Alexandrescu, Jennifer A Cotter, Jayne Vogelzang, Varun Bhave, Marilyn M Li, Jianling Ji, Jamal K Benhamida, Marc K Rosenblum, Tejus A Bale, Nancy ...> ;Neuro-Oncology. 2023 Jan 5
5 citations
Coping with glioblastoma: prognostic communication and prognostic understanding among patients with recurrent glioblastoma, caregivers, and oncologists.
Leah E Walsh, Laura C Polacek, Katherine Panageas, Anne Reiner, Tobias Walbert, Alissa A Thomas, Justin Buthorn, Allison Sigler, Holly G Prigerson, Allison J Applebaum...> ;Journal of Neuro-Oncology. 2022 May 1
51 citations
International expert consensus recommendations for the diagnosis and treatment of Langerhans cell histiocytosis in adults.
Gaurav Goyal, Abdellatif Tazi, Ronald S Go, Karen L Rech, Jennifer L Picarsic, Robert Vassallo, Jason R Young, Christian W Cox, Jan Van Laar, Michelle L Hermiston, Xin...> ;Blood. 2022 Apr 28
5 citations
Rosai-Dorfman-Destombes disease of the nervous system: a systematic literature review.
Ruham Alshiekh Nasany, Anne S Reiner, Jasmine H Francis, Oussama Abla, Katherine S Panageas, Eli L Diamond> ;Orphanet Journal of Rare Diseases. 2022 Mar 2
8 citations
A qualitative exploration of the feasibility and acceptability of Meaning-Centered Psychotherapy for Cancer Caregivers.
A J Applebaum, K E Roberts, K Lynch, R Gebert, M Loschiavo, M Behrens, L E Walsh, L C Polacek, E L Diamond, W S Breitbart> ;Palliative & Supportive Care. 2022 Oct 1
2 citations
A Population-Based Study of Treatment and Survival in Older Glioma Patients.
Anne S Reiner, Stephanie M Lobaugh, Selin Gonen, Eli L Diamond, Katherine S Panageas> ;JNCI Cancer Spectrum. 2022 Jan 5
2 citations
Progressive nodular histiocytosis in a 9-year-old boy treated with cobimetinib.
María Marta Buján, Cristian Sánchez La Rosa, María Laura Galluzzo Mutti, Jorge Braier, Eli L Diamond> ;Pediatric Dermatology. 2022 Jan 1
3 citations
MicroRNA-15a-5p acts as a tumor suppressor in histiocytosis by mediating CXCL10-ERK-LIN28a-let-7 axis.
Ran Weissman, Eli L. Diamond, Julien Haroche, Benjamin H. Durham, Fleur Cohen, Justin Buthorn, Zahir Amoura, Jean-François Emile, Roei D Mazor, Noam Shomron, Omar Abde...> ;Leukemia. 2021 Nov 16
50 citations
ALK+ histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition.
Paul Geraeds Kemps, Jennifer Picarsic, Benjamin H. Durham, Zofia Hélias-Rodzewicz, Laura Sophia Hiemcke-Jiwa, Cor van den Bos, Marianne D. van de Wetering, Carel J. M....> ;Blood. 2021 Nov 2
20 citations
Histiocytic Neoplasms, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.
Ronald S. Go, Eric D. Jacobsen, Robert A. Baiocchi, Ilia Buhtoiarov, Erin Butler, Patrick K Campbell, Don W. Coulter, Eli L. Diamond, Aron Flagg, Aaron M. Goodman, Gau...> ;Journal of the National Comprehensive Cancer Network. 2021 Nov 1
1 citations
Ethics consultations in neuro-oncology.
Ugur Sener, Elizabeth Neil, Amy E Scharf, Alan Carver, Justin B. Buthorn, Dana Bossert, Allison Sigler, Louis Voigt, Eli L. Diamond> ;Neuro-Oncology Practice. 2021 Jun 19
Join now to see all

Press Mentions

FDA Approves First Treatment for Patients with All Forms of HistiocytosisJanuary 30th, 2023
High Response Rate in Histiocytic Disease with MEK InhibitionJanuary 3rd, 2018
NCCN Foundation Awards Grants to Five Young InvestigatorsApril 1st, 2016

Hospital Affiliations

Memorial Sloan Kettering Cancer CenterNew York, New York
Memorial Hospital for Cancer and allied DiseasesBasking Ridge, New Jersey